A real-world clinical experience on effectiveness of remogliflozin etabonate in management of Indian patients with T2DM

被引：0
|
作者：
Mahapatra, H. [1 ]
Dalai, S. [2 ]
Sahoo, A. [3 ]
Khuntia, M. [4 ]
机构：
[1] IMS & SUM Hosp, Dept Endocrinol, Sevayan Diabet Ctr, Bhubaneswar, India
[2] IMS & SUM Hosp, Dept Med, Bhubaneswar, India
[3] IMS & SUM Hosp, Dept Endocrinol, Bhubaneswar, India
[4] Sevayan Diabet Ctr, Dept Endocrinol, Bhubaneswar, India
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2022年 / 186卷
关键词：
D O I：
10.1016/j.diabres.2022.109511
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF21-0310
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Real-World Study of Delayed Initiation of Insulin and Associated Factors Among Elderly Patients With Type 2 Diabetes Mellitus (T2DM)
    Bhattacharya, Rituparna
    Zhou, Steve
    Wei, Wenhui
    Ajmera, Mayank
    Ling, John
    Sambamoorthi, Usha
    [J]. DIABETES, 2013, 62 : A323 - A323
  • [42] Novel Use of Natural Language Processing to Identify Reasons for Insulin Discontinuation in Patients with T2DM: A Real-World Evidence Study
    Wu, Jianmin
    Morrison, Fritha J.
    Zhao, Zhenxiang
    He, Xuanyao
    Shubina, Maria
    Malmasi, Shervin
    Ge, Wendong
    Peng, Xiaomei
    Turchin, Alexander
    [J]. DIABETES, 2019, 68
  • [43] Long-Term Testosterone Therapy Results in Remission of Type 2 Diabetes (T2DM) in 34.3% (61 of 178) Men with Hypogonadism and T2DM in a Real-World Registry Study
    Haider, Karim S.
    Haider, Ahmad
    Saad, Farid
    [J]. DIABETES, 2020, 69
  • [44] Real-world clinical experience of IDegLira in the management of adolescents with type 2 diabetes
    Ashraf, T.
    Majeed, M.
    Siddiqui, M.
    Osman, A.
    Mohammed, N.
    Lessan, N.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [45] COST-EFFECTIVENESS OF A FLASH GLUCOSE MONITORING SYSTEM BASED ON REAL-WORLD USAGE FOR TYPE 2 DIABETES (T2DM) PATIENTS USING INTENSIVE INSULIN: A SWEDISH PERSPECTIVE
    Bilir, S. P.
    Spwehler, E. A.
    Hellmund, R.
    Munakata, J.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A587 - A587
  • [46] Real-world clinical experience of Xultophy in the management of patients with type 2 diabetes in a secondary care clinic
    Williams, David M.
    Shrikrishnapalasuriyar, Natasha
    Syed, Waheeba
    Yin, Win L.
    Chudleigh, Richard
    Bain, Stephen C.
    Price, David E.
    Stephens, Jeffrey W.
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (06) : 1079 - 1082
  • [47] Association of Treatment Persistence and Adherence With Real-World Outcomes Among Insulin-Treated Patients With Type 2 Diabetes Mellitus (T2DM)
    Wei, Wenhui
    Pan, Chunshen
    Xie, Lin
    Baser, Onur
    [J]. DIABETES, 2012, 61 : A4 - A4
  • [48] REAL-WORLD INCIDENCE OF HYPOGLYCEMIA AND ASSOCIATED COSTS AMONG INSULIN GLARGINE-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Xie, L.
    Wei, W.
    Pan, C.
    Baser, O.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A493 - A493
  • [49] THE FORGOTTEN POPULATIONS: REAL-WORLD PATIENTS WITH T2DM NOT MEETING ELIGIBILITY CRITERIA OF THE GLARGINE 300 U/ML EDITION AND BRIGHT RCTS
    Mauricio, D.
    Westerbacka, J.
    Nicholls, C.
    Wu, J.
    Gupta, R.
    Menon, A.
    Eliasson, B.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A91 - A91
  • [50] Real-World A1C Changes and Prescribing Provider Types among T2DM Patients Initiating Treatment with Oral Semaglutide
    Frazer, Monica S.
    Swift, Caroline
    Leszko, Michael
    Sargent, Andrew
    Buysman, Erin
    Alvarez, Sara B.
    Noone, Joshua
    Guevarra, Mico
    [J]. DIABETES, 2022, 71
12345